Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Parsons James T.
Relationship:   Chief Financial Officer
City:   Minneapolis
State:   MN
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   59,937    

Indirect Shares

  0      
Direct Value   $151,641    

Indirect Value

  $0      
Total Shares   59,937      
Total Value   $151,641      


Diamedica Therapeutics Inc.
 $151,641 Diamedica Therapeutics Inc.
 $151,641
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Diamedica Therapeutics Inc. DMAC Director 2024-01-02 59,937 2018-12-11 0    Premium*  
            Trillium Therapeutics Inc TRIL Chief Financial Officer 2021-01-08 0 2021-01-08 0    Premium*  
* Premium Members only  

Records found :    6         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
DMAC Diamedica Therapeutics In... Director   –       •      –    2024-01-02 4 A $2.80 $59,998 D/D 21,428 59,937 0 -
DMAC Diamedica Therapeutics In... Director   –       •      –    2022-01-03 4 A $3.58 $60,047 D/D 16,773 38,509 0 -
TRIL Trillium Therapeutics Inc Chief Financial Officer   •       –      –    2021-01-08 4 OE $7.24 $61,616 D/D 8,505 8,505 0 -
TRIL Trillium Therapeutics Inc Chief Financial Officer   •       –      –    2021-01-08 4 AS $15.79 $134,271 D/D (8,505) 0 0 %
DMAC Diamedica Therapeutics In... Director   –       •      –    2020-06-01 4 A $4.59 $37,188 D/D 8,102 14,202 0 -
DMAC Diamedica Therapeutics In... Director   –       •      –    2018-12-11 4 B $4.00 $9,000 D/D 2,250 6,100 2.39 -

  6  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed